Ewa Jachimczak

Ewa Jachimczak

Auto-generated profile, based on publicly available information

Ewa Jachimczak

University Hospital in Krakow, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
JKJulia Kozicka
Julia Kozicka
MMMarcin Mazur
Marcin Mazur
EWEwa Wojtanowska
Ewa Wojtanowska
EJEwa Jachimczak
Ewa Jachimczak
PJPaulina Jaruga
Paulina Jaruga
HKHanna Klimczyk
Hanna Klimczyk
Iron deficiency, including non-anaemic iron deficiency (NAID), is a common problem among young, menstruating female athletes, requiring precise differentiation from ‘athlete’s anaemia’, which is a physiological adaptive haemodilution. The aim of this narrative review was to summaries the mechanisms, prevalence, diagnostic principles, and clinical and performance-related consequences of these disorders. Epidemiological data indicate that hypoferritinaemia (ferritin ≤30 ng/mL) affects up to 47% of young female athletes, and 23.1% develop overt anaemia according to WHO criteria. The Pathomechanism of the negative iron balance is multifactorial and includes losses through sweat, gastrointestinal micro bleeding, mechanical haemolysis, and exercise-induced increases in interleukin-6 and hepcidin, which temporarily block intestinal iron absorption and recycling. It has also been shown that aerobic training is associated with a poorer haematological profile than anaerobic training. The consequences of NAID extend beyond reduced physical performance and fatigue, also including a decrease in bone mineral density and an increased risk of stress injuries to the lower limbs. In laboratory diagnostics, haemoglobin alone has been shown to have low sensitivity, which justifies routine measurement of ferritin (with the sports threshold raised to <30–35 ng/mL), sTfR and TSAT. In summary, optimal therapeutic management should be holistic, encompassing the provision of adequate energy intake, monitoring of vitamin levels (D, B12, folic acid) and targeted, 6–8-week course of oral supplementation in confirmed cases, whilst strictly avoiding the routine administration of high doses and intravenous infusions without clear laboratory indications.

30 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JPJulia Paczyna
Julia Paczyna
EJEwa Jachimczak
Ewa Jachimczak
EWEwa Wojtanowska
Ewa Wojtanowska
PJPaulina Jaruga
Paulina Jaruga
KGKarolina Grodkowska-Szukała
Karolina Grodkowska-Szukała
VGVanessa Gąsiorowska
Vanessa Gąsiorowska
Background and Aim: Delirium in the Intensive Care Unit (ICU) is a complex dysfunction that poses not only a clinical threat but also a massive organizational challenge, affecting the quality of care and staff well-being. This review aims to systematize knowledge on innovative strategies for delirium management, with a specific focus on mitigating nursing burnout and implementing the integrated ABCDEF bundle as an organizational protocol in light of the PADIS (2025) and ESAIC (2024) guidelines. Methodology: A narrative literature review (2015–2026) was conducted using PubMed/MEDLINE, Scopus, and the Cochrane Library, focusing on management innovations, burnout research, and non-pharmacological interventions. Results: Traditional, pharmacologically driven methods fail to yield expected results, and the growing workload drives a severe staffing crisis. The application of the integrated ABCDEF bundle (early mobilization, analgosedation optimization) as a structural innovation in daily workflow reduces delirium incidence by 50%. The routine use of antipsychotic medications neither improves patient outcomes nor relieves system burdens. Conclusion: Combating delirium requires a transformation of the organizational culture within the ICU. Implementing the "Awake and Walking ICU" concept significantly improves patient outcomes, mitigates the socio-economic impact of Post-Intensive Care Syndrome (PICS), and effectively protects nursing staff from severe occupational burnout.

30 May 2026 in Quality in Sport
Verified
Journal Article
Open access
NWNatalia Wdowiak
Natalia Wdowiak
GCGabriela Czerepak
Gabriela Czerepak
PJPaulina Jaruga
Paulina Jaruga
EJEwa Jachimczuk
Ewa Jachimczuk
KBKatarzyna Bednarz
Katarzyna Bednarz
NSNatalia Smyczyńska
Natalia Smyczyńska
Background: The rapid advancement of implantology necessitates the use of extraction methods that preserve bone tissue. Aim: The objective of this study is to review the literature on periotomes as tools for atraumatic tooth extraction, evaluate their clinical benefits, and assess periotome models currently available on the market. Materials and methods: A review of the available scientific literature from the years 2004-2025 was conducted to evaluate the clinical application of periotomes, and their impact on alveolar bone preservation and implant treatment outcomes. Results: Periotomes allow practitioners to precisely severe the periodontal ligament, minimizing trauma to the bone and soft tissues. Unlike traditional methods, they do not require forceful luxation. Studies show that their use is associated with less bone loss than with piezotomes and faster wound healing. These instruments come in many variants (straight, curved, titanium), allowing them to be adapted to the tooth’s morphology. Conclusions: The use of periotomes is an efficient and cost-effective method for preserving the alveolar ridge. These instruments reduce post-operative pain and are essential for preparing the implant site, offering a safe alternative to more invasive techniques.

22 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
PJPaulina Jaruga
Paulina Jaruga
EJEwa Jachimczak
Ewa Jachimczak
VGVanessa Gąsiorowska
Vanessa Gąsiorowska
KGKarolina Grodkowska-Szukała
Karolina Grodkowska-Szukała
JPJulia Paczyna
Julia Paczyna
NSNatalia Smyczyńska
Natalia Smyczyńska
Glioblastoma is the most common and most aggressive primary malignant tumor of the central nervous system in adults and remains associated with a very poor prognosis despite multimodal treatment. The current standard of care consists of maximal safe surgical resection followed by radiotherapy and temozolomide-based chemotherapy; however, the effectiveness of this strategy is limited by marked tumor heterogeneity, the infiltrative growth pattern, the presence of the blood–brain barrier, and the immunosuppressive tumor microenvironment. The aim of this paper is to review current standards of GBM treatment as well as emerging therapeutic strategies under development. Analysis of the available evidence indicates that novel approaches such as intraoperative 18F-FET PET, intraoperative radiotherapy, local temozolomide delivery using hydrogel-based systems, intranasal drug administration, NanoTherm® therapy, and CAR-T immunotherapy may increase treatment precision, improve local tumor control, and partially overcome the limitations of systemic therapy. However, most of these methods remain investigational or experimental, and their actual impact on overall survival requires further validation. The integration of advanced imaging, local treatment modalities, and molecularly targeted therapies appears to be the most promising direction for future GBM management.

28 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
VGVanessa Gąsiorowska
Vanessa Gąsiorowska
KGKarolina Grodkowska-Szukała
Karolina Grodkowska-Szukała
EJEwa Jachimczak
Ewa Jachimczak
NSNatalia Smyczyńska
Natalia Smyczyńska
EWEwa Wojtanowska
Ewa Wojtanowska
MMMarcin Mazur
Marcin Mazur
Liquid biopsy has emerged as an important minimally invasive technology in contemporary oncology, enabling repeated assessment of tumor-derived molecular information through blood and other biological fluids. Circulating tumor DNA (ctDNA), circulating tumor cells, cell-free DNA methylation patterns, extracellular vesicles, circulating RNA and fragmentomic signatures may provide dynamic information about tumor burden, treatment response, molecular residual disease and cancer recurrence. However, liquid biopsy generates complex, multidimensional datasets in which tumor-derived signals may be extremely small relative to biological and technical background. Artificial intelligence (AI), including machine learning and deep learning, offers a potential computational framework for integrating these heterogeneous signals and generating clinically meaningful predictions. This review examines the emerging convergence of AI and liquid biopsy, with particular emphasis on longitudinal cancer monitoring rather than cancer detection alone. The available PubMed-indexed literature was reviewed to evaluate the potential role of AI-enhanced liquid biopsy in treatment-response assessment, minimal residual disease detection, prediction of treatment resistance and early identification of disease recurrence. Evidence from colorectal, lung, breast, hepatocellular and other solid tumors is discussed. The review also addresses major translational barriers, including low tumor shedding, clonal hematopoiesis, analytical heterogeneity, external validation, algorithmic bias, interpretability, data privacy, cost and uncertainty regarding clinical actionability. Current evidence indicates that AI can extract complementary biological information from complex circulating biomarker datasets, but prospective validation is still required before widespread implementation. AI-enhanced liquid biopsy may ultimately support a transition from episodic, imaging-centered surveillance toward personalized, dynamic and molecularly informed cancer monitoring.

25 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MMMateusz Michalak
Mateusz Michalak
PKPiotr Kucharczyk
Piotr Kucharczyk
TSTomasz Szwarc
Tomasz Szwarc
KPKarolina ParzęCka
Karolina ParzęCka
PJPaulina Jaruga
Paulina Jaruga
ACAleksandra Czapla
Aleksandra Czapla
Introduction: Huperzia selago is a natural source of huperzine A (HupA), a potent and reversible acetylcholinesterase (AChE) inhibitor with therapeutic potential in Alzheimer’s disease. Due to limited natural resources, alternative methods for alkaloid production—such as in vitro cultures—are being explored. Acetylcholine (ACh) functions as a signaling molecule in plants, but its influence on alkaloid biosynthesis in clubmosses has not yet been investigated [1-5]. Aim: To evaluate the effect of exogenous ACh on the biosynthesis of HupA, huperzine B (HupB), and lycopodine in H. selago gametophyte cultures. Methods: Gametophytes were grown in vitro on Whittier and Storchova media supplemented with acetylcholine chloride at concentrations of 0 (control), 1, 10, 100, and 1000 µM. Biomass was collected after 2, 4, 6, 8, and 10 weeks, lyophilized, and extracted with methanol. Quantitative analysis of HupA, HupB, and lycopodine was performed using HPLC-DAD [2, 4-12]. Results: Control cultures showed high HupA content (mean 3.34 mg/g DW), ranging from 3.01 to 4.22 mg/g DW, with a maximum at week 8. HupB was detected only at week 8 (0.44 mg/g DW). In contrast, none of the ACh-treated cultures contained detectable HupA or HupB. A significant increase (p<0.05) in lycopodine content was observed in cultures treated with 10 µM ACh, reaching up to 16.72 mg/g DW at week 8. Other ACh concentrations did not significantly affect lycopodine levels compared to the control. Conclusions: selago gametophytes in vitro are an efficient source of HupA and HupB. Acetylcholine inhibits the biosynthesis of HupA and HupB. Acetylcholine at 10 µM significantly enhances lycopodine biosynthesis. Culture duration influences alkaloid content. The results indicate a significant and selective role of ACh in regulating alkaloid biosynthetic pathways in H. selago.